The status of IGVH and TP53 genes is considered crucial in recent five-variable International Prognostic Index for Patients with CLL (CLL-IPI) proposed by The International CLL-IPI working group [29]. The gene discussed is TP53; the disease is B-cell chronic lymphocytic leukemia.